Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Intimate Rose vs Royal Medical Center

Intimate Rose
Graded #136

Higher grade

vs+19.699999999999996
Royal Medical Center
Graded #492

Lower grade

The verdict

Intimate Rose takes it — 69.1/100 to 49.4/100.

Intimate Rose grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Intimate Rose is an established US women's and pelvic-health brand that has added an online weight-management program offering compounded GLP-1 medication.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIntimate Rose +43
65
22
Dose & formulationIntimate Rose +54
96
42
Clinical oversightIntimate Rose +14
76
62
Labs & monitoringRoyal Medical Center +34
52
86
FulfillmentIntimate Rose +16
64
48
Contract termsRoyal Medical Center +18
37
55
Intimate Rose · left barRoyal Medical Center · right bar

The numbers

MetricIntimate RoseRoyal Medical Center
WeighScore69.1/10049.4/100
GradeCC
Scorecard rank#136#492
Semaglutide$169/mo (all doses, compounded)Not disclosed
Tirzepatide$169/mo (all doses, compounded)$450/mo (2.5 mg dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Intimate Rose

Graded #136 · C

Strengths

  • Transparent pricing from 169 dollars per month shown upfront, not gated behind intake
  • Medication and free delivery included, HSA and FSA eligible, no contract
  • Backed by an established women's-health brand using the OpenLoop provider network

Where it loses points

  • State availability not published
  • Oral compounded GLP-1 only; no injectable option shown
  • No specific compounding pharmacy named (network fulfillment via OpenLoop)
Royal Medical Center

Graded #492 · C

Strengths

  • Physician founder Dr. Dagoberto Rodriguez, MD — Emory residency, former Coral Springs Medical Center chairman, U Miami faculty
  • Tirzepatide pricing fully itemized by dose tier ($450 / $650 / $800 / $1,100) — more transparent than 'starting at' floors
  • All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups
  • Broad catalog (HRT, TRT, peptides, ED, hair, vitamins) reflects an established multi-program clinic
  • Florida physician with 30+ years of practice — a strong physician-led care signal

Where it loses points

  • Operating legal entity not disclosed — only the 'Royal Medical Center' brand surfaced
  • Pharmacy partner not named — buyers can't verify licensure or 503A/503B status
  • No LegitScript badge displayed
  • States served not enumerated — site says 'nationwide' with no state list
  • Headline 'starting at $116/mo' conflicts with the actual $450/mo tirzepatide floor

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard